𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate-specific antigen velocity in untreated, localized prostate cancer

✍ Scribed by Ramachandran Venkitaraman; Andrew Norman; Ruth Woode-Amissah; David Dearnaley; Alan Horwich; Robert Huddart; Chris Parker


Book ID
109053540
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
140 KB
Volume
0
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prostate-specific antigen velocity and p
✍ Paul F. Pinsky; Gerald Andriole; E. David Crawford; David Chia; Barnett S. Krame πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract ## BACKGROUND. Increased preoperative prostate‐specific antigen (PSA) velocity (PSAV) has been associated with increased prostate cancer mortality and higher Gleason scores. The authors evaluated the relation between PSAV, biopsy Gleason score, and pathologic stage in men who were enro

Monoclonal prostate-specific antigen in
✍ R. Joseph Babaian; Joseph L. Camps; Dino N. Frangos; Edilberto I. Ramirez; Denis πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 590 KB

The authors evaluated 440 men with clinically staged and untreated prostate cancer with a monoclonal prostate-specific antigen (PSA) assay. The serum PSA value correlated significantly with both the stage and grade of disease (P < 0.00005). The relationships between PSA and consecutive Stages A, B,

Prostate-specific antigen in screening o
✍ Dr. T. Ming Chu πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 467 KB πŸ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren